These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11291053)
1. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Schulte KM; Beyer A; Köhrer K; Oberhäuser S; Röher HD Int J Cancer; 2001 Apr; 92(2):249-56. PubMed ID: 11291053 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. An S; Bleu T; Zheng Y; Goetzl EJ Mol Pharmacol; 1998 Nov; 54(5):881-8. PubMed ID: 9804623 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. An S; Bleu T; Hallmark OG; Goetzl EJ J Biol Chem; 1998 Apr; 273(14):7906-10. PubMed ID: 9525886 [TBL] [Abstract][Full Text] [Related]
6. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Contos JJ; Ishii I; Fukushima N; Kingsbury MA; Ye X; Kawamura S; Brown JH; Chun J Mol Cell Biol; 2002 Oct; 22(19):6921-9. PubMed ID: 12215548 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors. Hama K; Bandoh K; Kakehi Y; Aoki J; Arai H FEBS Lett; 2002 Jul; 523(1-3):187-92. PubMed ID: 12123830 [TBL] [Abstract][Full Text] [Related]
8. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Mills GB; Eder A; Fang X; Hasegawa Y; Mao M; Lu Y; Tanyi J; Tabassam FH; Wiener J; Lapushin R; Yu S; Parrott JA; Compton T; Tribley W; Fishman D; Stack MS; Gaudette D; Jaffe R; Furui T; Aoki J; Erickson JR Cancer Treat Res; 2002; 107():259-83. PubMed ID: 11775454 [TBL] [Abstract][Full Text] [Related]
9. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Fang X; Gaudette D; Furui T; Mao M; Estrella V; Eder A; Pustilnik T; Sasagawa T; Lapushin R; Yu S; Jaffe RB; Wiener JR; Erickson JR; Mills GB Ann N Y Acad Sci; 2000 Apr; 905():188-208. PubMed ID: 10818454 [TBL] [Abstract][Full Text] [Related]
10. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. Hu YL; Albanese C; Pestell RG; Jaffe RB J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. An S; Dickens MA; Bleu T; Hallmark OG; Goetzl EJ Biochem Biophys Res Commun; 1997 Feb; 231(3):619-22. PubMed ID: 9070858 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein. Hernández M; Barrero MJ; Crespo MS; Nieto ML J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838 [TBL] [Abstract][Full Text] [Related]
14. EDG receptors and hepatic pathophysiology of LPA and S1P: EDG-ology of liver injury. Svetlov SI; Sautin YY; Crawford JM Biochim Biophys Acta; 2002 May; 1582(1-3):251-6. PubMed ID: 12069835 [TBL] [Abstract][Full Text] [Related]
15. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Chen M; Towers LN; O'Connor KL Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489 [TBL] [Abstract][Full Text] [Related]
18. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. Takuwa Y; Takuwa N; Sugimoto N J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970 [TBL] [Abstract][Full Text] [Related]
19. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors. Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399 [TBL] [Abstract][Full Text] [Related]
20. Native and recombinant human Edg4 receptor-mediated Ca(2+) signalling. Simpson PB; Villullas IR; Schurov I; Kerby J; Millard R; Haldon C; Beer MS; McAllister G Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):31-40. PubMed ID: 15090154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]